11/08/2022 - Press release
The research, led by the Barcelonaβeta Brain Research Center (BBRC), research center of the Pasqual Maragall Foundation, the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the University of Gothenburg, has been published in the prestigious journal Nature Medicine. The study, which used data from almost 400 participants of the ALFA+ Study, which has the impetus of the "la Caixa" Foundation, determines that the biomarkers p-tau231 and p-tau217 measured in the blood are suitable for indicating brain changes related to the amyloid protein in people without cognitive symptoms. The results of this research make p-tau231 a very promising blood biomarker to detect early those middle-aged people who show the first brain changes associated with Alzheimer's and to conduct clinical trials aimed at this early stage of Alzheimer's.
01/08/2022 - General information
During the months of April, May and June, the cycle "Our brain, that great unknown" organized by the IMIM and the network of libraries of Barcelona, has been carried out with great success of attendees. More than 400 people have been able to participate in this cycle that is part of the "Visions of Science" project that the Barcelona Libraries have been carrying out for years. The cycle has lasted 8 weeks, was free and open to everyone. It dealt with topics related to the brain and allowed attendees to learn about the latest data provided by new scientific advances in this field thanks to the participation as speakers of the best experts from the Hospital del Mar and IMIM.
Més informació "Successful cycle "Our brain, that great unknown" with more than 400 attendees"
28/07/2023 - Press release
A study by cardiologists at Hospital del Mar and researchers at the Hospital del Mar Medical Research Institute reveals that more than half of the people treated for the arrhythmia known as atrial flutter will suffer an episode of atrial fibrillation in less than a year. The risk of atrial fibrillation reaches 86% in those patients who score higher on a risk scale designed by the team, prompting the need for more accurate monitoring of these patients because of the likelihood that they could suffer other cardiovascular problems, such as a stroke. The study, published in the Journal of Cardiology, was funded by the 2014 La Marató de TV3, dedicated to heart disease.
Més informació "Patients with arrhythmia are at greater risk of suffering atrial fibrillation"
26/07/2022 - General information
This is the question that Dr. Daniel Guinart, Dr. Víctor Pérez and Dr. Benedikt Amann, researchers from the Neurosciences Research Programme at the Hospital del Mar Medical Research Institute, attempt to answer in a letter recently published in The Lancet. The role peer reviewers of scientific articles play and the debate on whether their work should be remunerated are the focus of a letter by Dr. Daniel Guinart, Dr. Víctor Pérez and Dr. Benedikt Amann, researchers from the Hospital del Mar Medical Research Institute's Neurosciences Research Programme (IMIM-Hospital del Mar) that has been published in The Lancet. It is a voluntary task, based on a "code of honour", as the authors put it, but which in recent times has become an exploitative system.
Més informació "Should reviewers of scientific journal articles be paid a wage?"
25/07/2022 - Institutional news
Monday 25 July marks the 30th anniversary of the inauguration of the Barcelona Olympic Games, which represented a historic milestone for the city. During this great event, the Anti-Doping Laboratory of the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) was entrusted with the anti-doping controls of the athletes at both the Barcelona 92 Olympic and Paralympic Games. The laboratory was set up in 1985 as part of the Barcelona Olympic bid. Its designation as an Olympic laboratory allowed the modernization of the facilities and equipment of both the laboratory itself and the IMIM. The laboratory took up anarea of 1100 m2, and during the Games it worked 24 hours a day. In total, close to 110 people were involved in the anti-doping work, considering the laboratory staff, guest scientific staff, volunteers and support staff.
Més informació "30 years of the Olympic Anti-Doping Laboratory"
20/07/2022 - General information
The IMIM-Hospital del Mar has been awarded three grants in the latest call. They are aimed at promoting the hiring of researchers with a doctoral degree at Spanish research centres. Three researchers from IMIM-Hospital del Mar have been selected in the latest call for the Juan de la Cierva-incorporation grants from the State Research Agency. The successful candidates are Joan Jiménez Balado, from the Neurovascular Research Group, Ana Rocío Conde Moro, from the Cellular Mechanisms in Physiological and Pathological Behaviour Research Group, and Helena Garcia Mieres, from the Health Services Research Group.
14/07/2022 - General information
After the success of "La mare de la ciència", the PRBB's science outreach podcast in Catalan, June saw the launch of "Absolutos y Relativos", the second science outreach podcast from the PRBB, which this time will be in Spanish. On 14 July, Patricia Robledo, a researcher from the Integrated Pharmacology and Systems Neuroscience research group at the IMIM, explains the neuroscience and drug studies she is carrying out, and talks about her research career, which is closely linked to psychology.
12/07/2022 - General information
This is one of the fifteen biomedical projects selected in the CaixaResearch Validate call. In this case, the study led by the researcher from the Hospital del Mar Medical Research Institute seeks effective immunotherapy treatment for breast tumours. The "la Caixa" Foundation is supporting 15 leading biomedical research projects in Spain and Portugal in the CaixaResearch Validate 2022 call. These are early-stage projects that the organisation wants to support to accelerate their arrival on the market, thereby helping them reach patients who may need them. Among those selected is a project led by Dr. Toni Celià-Terrassa, who heads up the Cancer Stem Cells and Metastasis Dynamics laboratory at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar).
04/07/2022 - Covid-19
The possibility of re-freezing vials once they are prepared may enable the manipulation of vaccines in the country of origin, freezing the syringes, and sending them to their destination for immediate use, without the need for a major infrastructure. The shelf life of the re-frozen vaccine is at least one month.
07/07/2022 - Covid-19
A study on the vaccine response of patients with primary antibody deficiency carried out by the Functional Unit of Primary Immunodeficiencies at Hospital del Mar together with the dibi Network (Reference Laboratory of Catalonia) has revealed that a good number of these people have antibodies against SARS-CoV-2 without actually having contracted COVID-19. The study, published in the journal Immunology, is the first to certify the transmission of antinucleocapsid antibodies (ANC) from donors to patients with primary immunodeficiency.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
